Personalized identification of altered pathways in cancer using accumulated normal tissue data

Bioinformatics

Volumn 30, Issue 17, 2014, Pages

  Ahn, Taejin ^a,b   Lee, Eunjin ^a   Huh, Nam ^a   Park, Taesung ^b,c  

^a Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^b Interdisciplinary Program in Bioinformatics   (United States)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; COLON; COLON TUMOR; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LUNG; LUNG TUMOR; METABOLISM; MORTALITY; NEOPLASM; PROCEDURES; SURVIVAL;

ADENOCARCINOMA; COLON; COLONIC NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; LUNG; LUNG NEOPLASMS; NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84907033003     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btu449     Document Type: Conference Paper

References (30)

1. Bandres, E. et al. (2007) A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes B colon cancer patients. Oncol. Rep., 17, 1089-1094.
2. Barletta, J.A. et al. (2010) Prognostic significance of grading in lung adenocarcinoma. Cancer, 116, 659-669.
3. Barrett, T. et al. (2012) NCBI GEO: archive for functional genomics data sets- update. Nucleic Acids Res., 41, D991-D995.
4. Barrier, A. et al. (2006) Stage II colon cancer prognosis prediction by tumor gene expression profiling. J. Clin. Oncol., 24, 4685-4691.
5. Barrier, A. et al. (2007) Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling. Oncogene, 26, 2642-2648.
6. Beer, D.G. et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 8, 816-824.
7. Bolstad, B.M. et al. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 19, 185-193.
8. Breitling, R. et al. (2004) Iterative Group Analysis (iGA): a simple tool to enhance sensitivity and facilitate interpretation of microarray experiments. BMC Bioinformatics, 5, 34.
9. Bryant, C.M. et al. (2010) Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study. PLoS One, 5, e11712.
10. Croft, D. et al. (2011) Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res., 39, D691-D697.
11. Dancey, J.E. et al. (2012) The genetic basis for cancer treatment decisions. Cell, 148, 409-420.
12. Drier, Y. et al. (2013) Pathway-based personalized analysis of cancer. Proc. Natl Acad. Sci. USA, 110, 6388-6393.
13. Eschrich, S. et al. (2005) Molecular staging for survival prediction of colorectal cancer patients. J. Clin. Oncol., 23, 3526-3535.
14. Hou, J. et al. (2010) Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One, 5, e10312.
15. Irizarry, R.A. et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-264.
16. Jones, S.J. et al. (2010) Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol., 11, R82.
17. Khatri, P. et al. (2012) Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput. Biol., 8, e1002375.
18. Kopetz, S. and Abbruzzese, J.L. (2009) Barriers to integrating gene profiling for stage ii colon cancer. Clin. Cancer Res., 15, 7451-7452.
19. Landi, M.T. et al. (2008) Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One, 3, e1651.
20. Lee, E.S. et al. (2008) Prediction of recurrence-free survival in postoperative nonsmall cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin. Cancer Res., 14, 7397-7404.
21. Lin, Y.H. et al. (2007) Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Clin. Cancer Res., 13, 498-507.
22. Lu, T.P. et al. (2011) Integrated analyses of copy number variations and gene expression in lung adenocarcinoma. PLoS One, 6, e24829.
23. Marisa, L. et al. (2013) Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med., 10, e1001453.
24. Munoz-Pinedo, C. et al. (2012) Cancer metabolism: current perspectives and future directions. Cell Death Dis., 3, e248.
25. Smith, J.J. et al. (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology, 138, 958-968.
26. Su, L.J. et al. (2007) Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics, 8, 140.
27. Subramanian, A. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550.
28. Tian, L. et al. (2005) Discovering statistically significant pathways in expression profiling studies. Proc. Natl Acad. Sci. USA, 102, 13544-13549.
29. Vaske, C.J. et al. (2010) Inference of patient-specific pathway activities from multidimensional cancer genomics data using PARADIGM. Bioinformatics, 26, i237-i245.
30. Wang, Y. et al. (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes B colon cancer. J. Clin. Oncol., 22, 1564-1571.